Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Rectal Bleeding Clinical Trial

Official title: Randomized Trial of Argon Plasma Coagulation Versus Argon Plasma Coagulation and Hemospray in the Therapy of Radiation Proctitis

Status Not yet recruiting

Clinical Trial Summary

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

Clinical Trial Description

20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Proctitis
• Rectal Bleeding

• NCT number: NCT02233933
• Study type: Interventional
• Source: British Columbia Cancer Agency
• Contact: Alan A Weiss, MD
• Phone: 7789979332
• Email: aweiss@bccancer.bc.ca
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 2014
• Completion date: December 2015